Phone
Address Talkabouturology, Russia, Nizhny Novgorod
Skype ukitcom
Email Talkabouturology@list.ru
                                    Talk about urology

Pembrolizumab/lenvatinib survival benefit sustained across RCC risk subgroups

https://www.urologytimes.com/view/pembrolizumab-lenvatinib-survival-benefit-sustained-across-rcc-risk-subgroups?fbclid=IwAR03T6LYxMKQDvsJurdG0FXOBwr4EdtLdJV7EJUtoRo43_5vBsTRL2r3i74 

Read more

Dr. Figlin on remaining questions from KEYNOTE-564 trial of adjuvant pembrolizumab in RCC

https://www.urologytimes.com/view/dr-figlin-on-remaining-questions-from-keynote-564-trial-of-adjuvant-pembrolizumab-in-rcc?fbclid=IwAR19JgbgAbxyej6DceOLnC10ZJ5unt735YAgTpLXD0NGkW0Bc9N_DCceh_4 

Read more

Update on advanced imaging in prostate cancer

https://www.urologytimes.com/view/update-on-advanced-imaging-in-prostate-cancer?fbclid=IwAR1h8qPfIxc-vpbGG3tTz7FdBLlJHPZxARkSUCTrhn4bncBt2D7-HBouW8E 

Read more

Dr. Ramasamy discusses myths about testosterone therapy

https://www.urologytimes.com/view/dr-ramasamy-discusses-myths-about-testosterone-therapy?fbclid=IwAR2-gPCf2BVFWTk9FWnv87oJKLAeTm_5x-uGrVusAH2bl9mkQUgXvXgba4k 

Read more

Video: Study backs increased PSA screening for younger African Americans

https://www.urologytimes.com/view/study-backs-increased-psa-screening-for-younger-african-americans?fbclid=IwAR2Kr9VzRDu1qDo1myOHNqyBSGuzZWlgDj_09xI5JRXyJxnhYehxFQ3K64Q 

Read more

Dr. Neal Shore on ODENZA study of patient preference between darolutamide and enzalutamide in mCRPC

https://www.urologytimes.com/view/dr-shore-on-study-of-patient-preference-between-darolutamide-and-enzalutamide-in-mcrpc?fbclid=IwAR29lOeHUdkhUYe_kGBLpOTNxxl0kk_WILmKBWQS67nX13mhNu_rSeND9vY 

Read more

GNRH agonists vs antagonists in prostate cancer: How to choose

https://www.urologytimes.com/view/gnrh-agonists-vs-antagonists-in-prostate-cancer-how-to-choose?fbclid=IwAR1fo4GyB2oyxI4TlzGqsI3epYHpaYPKJsUwhabraSlzmMilED4E8ug4_10 

Read more

EVENT: Register today for a Live Case Event with discussions on challenging patient cases in prostate cancer.

https://globalmeet.webcasts.com/starthere.jsp?ei=1448232&tp_key=25f388d20e&sti=social&fbclid=IwAR253GAUurPS283Oub08gl-XdCws2tNiNtVoU7R1_3KhVjX1YXBbRryKyr4 

Read more

Dr. Nizar Tannir on CANTATA study of telaglenastat plus cabozantinib in mRCC

https://www.urologytimes.com/view/dr-tannir-on-cantata-study-of-telaglenastat-plus-cabozantinib-in-mrcc?fbclid=IwAR1YsV37J519zTMyaQtB-biatv-ksWJ8delyY5vVsLt7b8zgkYZbpi_BITQ 

Read more

Dr. Galsky on how recurrence impacts QOL in muscle-invasive UC

https://www.urologytimes.com/view/dr-galsky-on-how-recurrence-impacts-qol-in-muscle-invasive-uc?fbclid=IwAR1jF_XFzIEf52PK3HvDfecDTIRDcCuEljZmtYiNRitls6iIedzV_btCWYQ 

Read more
View more